Nuwellis (NUWE) Operating Leases (2019 - 2025)

Nuwellis (NUWE) posted Operating Leases of $67000.0 for Q4 2025, down 47.66% on a QoQ basis from $128000.0 in Q3 2025, and down 78.18% year-over-year from $307000.0 in Q4 2024.

Nuwellis (NUWE) Operating Leases (2019 - 2025) Analysis & Trends

Nuwellis' Operating Leases history runs 7 years deep, the most recent figure standing at $67000.0 for Q4 2025.

  • Quarterly Operating Leases fell 78.18% year-over-year to $67000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $67000.0 (down 78.18% YoY) and the FY2025 annual result came in at $67000.0, down 78.18% from the prior year.
  • Operating Leases was $67000.0 for Q4 2025 at Nuwellis, down from $128000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $956000.0 in Q4 2021 and bottomed at $67000.0 in Q4 2025.
  • A 5-year average of $530941.2 and a median of $544000.0 in 2023 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2021 — Operating Leases surged 1638.18% — and 2025, when it tumbled 78.18%.
  • Nuwellis' Operating Leases stood at $956000.0 in 2021, then decreased by 20.5% to $760000.0 in 2022, then decreased by 28.42% to $544000.0 in 2023, then slumped by 43.57% to $307000.0 in 2024, then tumbled by 78.18% to $67000.0 in 2025.
  • Business Quant data shows NUWE's Operating Leases at $67000.0 in Q4 2025, $128000.0 in Q3 2025, and $189000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Nuwellis 613.80 -2.08 Mn 1.68 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 67,000.00
Sep 30, 2025 128,000.00
Jun 30, 2025 189,000.00
Mar 31, 2025 249,000.00
Dec 31, 2024 307,000.00
Sep 30, 2024 368,000.00
Jun 30, 2024 428,000.00
Mar 31, 2024 488,000.00
Dec 31, 2023 544,000.00
Sep 30, 2023 601,000.00
Jun 30, 2023 654,000.00
Mar 31, 2023 708,000.00
Dec 31, 2022 760,000.00
Sep 30, 2022 810,000.00
Jun 30, 2022 860,000.00
Mar 31, 2022 909,000.00
Dec 31, 2021 956,000.00
Dec 31, 2020 55,000.00
Sep 30, 2020 108,000.00
Jun 30, 2020 160,000.00